REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 161 filers reported holding REATA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $490,020 | -87.5% | 4,806 | -88.9% | 0.07% | -87.4% |
| Q1 2023 | $3,923,107 | +139.4% | 43,149 | +0.0% | 0.53% | +100.8% |
| Q4 2022 | $1,639,041 | +12.2% | 43,144 | -25.8% | 0.26% | +19.9% |
| Q3 2022 | $1,461,000 | -24.0% | 58,134 | -8.1% | 0.22% | +30.0% |
| Q2 2022 | $1,923,000 | +467.3% | 63,264 | +510.8% | 0.17% | +486.2% |
| Q1 2022 | $339,000 | – | 10,357 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DekaBank Deutsche Girozentrale | 17,000 | $2,930 | 0.01% |
| PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO | 93,711 | $1,612 | 0.00% |
| IFP Advisors, Inc | 300 | $51,708 | 0.00% |